Clinical Information
patient
|
XJ203787 |
Age
|
63 |
Gender
|
M |
Genotype
|
None |
Diagnosis
|
hepatocellular carcinoma |
HBV DNA
|
347IU/ml |
HBeAg
|
0 |
AFP(ng/ml)
|
6.6 |
PLT(log IU/mL)
|
233 |
HBcAb
|
1 |
HBsAb
|
0 |
HBeAb
|
0 |
HBsAg
|
1 |
ctDNA concentration
|
0.01311 |
marker
|
ctDNA- |
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
HBsAg (IU/ml)
|
57.97 |
BCLC
|
C |
ACJJ
|
II |
Tumor maximum size
|
4 |
Tumor count
|
1 |
MVI
|
M1 |
AFP-L3
|
0 |
PIVKA-II (mAU/ml)
|
84 |
CA199 (U/ml)
|
25.4 |
Cirrhosis history
|
0 |
Fatty liver
|
0 |
Hepatic encephalopathy (1-3)
|
1 |
Ascites (1-3)
|
1 |
TBIL (μmol/L)
|
1 |
ALB (g/L)
|
1 |
INR
|
1 |
Score
|
5 |
Child-Pugh stage
|
A |
HBV integration detection
|
No |
Integration number
|
0 |
HBV subtype frequency
|
None |
|
|